Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Results of Phase III study into treatment for NSCLC

Vanita Noronha, MBBS, MD, DM, of the Tata Memorial Center, Mumbai, India, discusses the results of a Phase III study investigating gefitinib versus combination therapy in the treatment of non-small cell lung cancer (NSCLC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.